Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis: beyond the itch that rashes.

Mark Boguniewicz1

  • 1Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, J 310, Denver, CO 80206, USA.

Immunology and Allergy Clinics of North America
|May 10, 2005
PubMed
Summary

The prevalence of atopic dermatitis is rising, often leading to asthma and allergies in children. Early intervention with topical calcineurin inhibitors and topical corticosteroids may be beneficial for managing this skin condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.

The British journal of dermatology·2026
Same author

Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Journal of asthma and allergy·2026
Same author

Atopic dermatitis Yardstick: A new era of topical and systemic treatments.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).

Pediatric dermatology·2026
Same author

Lebrikizumab is efficacious in adults and adolescents with moderate-to-severe atopic dermatitis regardless of atopic comorbidities.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025

Area of Science:

  • Immunology
  • Dermatology
  • Allergology

Background:

  • Atopic dermatitis prevalence is increasing globally.
  • Over 50% of children with atopic dermatitis develop asthma and allergies.
  • Understanding immune abnormalities in atopic dermatitis is crucial.

Purpose of the Study:

  • To explore the immune abnormalities underlying atopic dermatitis.
  • To discuss potential treatment strategies for atopic dermatitis.

Main Methods:

  • Review of recent studies on atopic dermatitis.
  • Analysis of immune mechanisms in chronic relapsing skin disease.

Main Results:

  • Atopic dermatitis is linked to significant immune system dysregulation.

Related Experiment Videos

  • A high comorbidity rate exists between atopic dermatitis, asthma, and allergies in children.

    • Conclusions:

    • Topical calcineurin inhibitors show promise for early intervention in atopic dermatitis.
    • Topical corticosteroids can be used as rescue therapy for atopic dermatitis.
    • Further research is needed to define optimal treatment approaches for atopic dermatitis.